...
首页> 外文期刊>World Journal of Surgical Oncology >Emergency endoscopic variceal ligation following variceal rupture in patients with advanced hepatocellular carcinoma and portal vein tumor thrombosis: a retrospective study
【24h】

Emergency endoscopic variceal ligation following variceal rupture in patients with advanced hepatocellular carcinoma and portal vein tumor thrombosis: a retrospective study

机译:晚期肝细胞癌合并门静脉肿瘤血栓形成患者静脉曲张破裂后紧急内镜静脉曲张结扎的回顾性研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The outcomes of treatment of ruptured varices in patients with hepatocellular carcinoma (HCC) and portal vein tumor thrombus (PVTT) are unclear. We therefore evaluated the long- (rebleeding and death) and short-term (immediate death within 24?h of variceal bleeding diagnosis) outcomes of patients with PVTT who underwent emergency variceal band ligation. Data on 62 patients with PVTT and endoscopically proven esophageal or gastric variceal bleeding from 2007 to 2012 were studied. In most cases, the varices were treated using endoscopic variceal band ligation (EVL). We assessed the patients’ rebleeding-free and overall survival using the Kaplan-Meier method, and a Cox proportional hazard model was used to analyze effect of independent factors on rebleeding-free and overall survival times. Most patients had decompensated cirrhosis and were classified as Child-Pugh class B (56?%) or C (36?%). A total of 35 patients (56?%) had PVTT in the main portal trunk. Among all patients, 58 (94?%) and 4 (6?%) had esophageal and gastric variceal bleeding, respectively. Bleeding was managed using EVL in all, but one patient (98?%) who was treated with a Sengstaken-Blakemore tube. A total of 24 patients (39.3?%) experienced rebleeding, and these patients had a median overall survival time of 36?days. A PVTT in the main portal trunk was predictive of rebleeding (hazard ratio 3.706, p?=?.0223), and α-fetoprotein-L3 levels <37.4?% (hazard ratio 0.464, p?=?0.015) and Child-Pugh class A/B (hazard ratio 0.398, p?=?0.007) were associated with overall survival. We observed 95 bleeding events in 62 patients. EVL achieved hemostasis in 92 of the 95 bleeding events, whereas seven immediate deaths occurred due to variceal bleeding (7/92, 7.6?%). All three bleeding events treated with modalities other than EVL resulted in immediate deaths. EVL is a safe and effective treatment of variceal ruptures in patients with HCC and PVTT. After successful hemostasis, alleviation of the underlying liver function impairment and tumor control are equally important for a good prognosis.
机译:肝细胞癌(HCC)和门静脉肿瘤血栓(PVTT)患者的静脉曲张破裂破裂的治疗结果尚不清楚。因此,我们评估了接受紧急静脉曲张绑扎术的PVTT患者的长期(出血和死亡)和短期(曲张静脉出血诊断后24小时内立即死亡)结局。研究对象为2007年至2012年的62例PVTT和经内镜证实的食管或胃静脉曲张破裂出血的患者。在大多数情况下,使用内窥镜静脉曲张绑扎术(EVL)治疗静脉曲张。我们使用Kaplan-Meier方法评估了患者的无再出血和总生存时间,并使用Cox比例风险模型分析了独立因素对无再出血和总生存时间的影响。大多数患者患有代偿性肝硬化,被归类为Child-Pugh B级(56%)或C级(36%)。主门主干中共有35例患者(56%)患有PVTT。在所有患者中,分别有58例(94%)和4例(6%)发生了食管和胃静脉曲张破裂出血。所有患者均使用EVL治疗出血,但有1名患者(98%)接受了Sengstaken-Blakemore管治疗。共有24例患者(39.3%)经历了再出血,这些患者的平均总生存时间为36天。主门主干中的PVTT可预示再出血(危险比3.706,p?= ?. 0223),α-甲胎蛋白-L3水平<37.4%(危险比0.464,p?=?0.015)和Child-Pugh A / B级(危险比0.398,p≤0.007)与总体生存率相关。我们观察到62例患者中有95例出血事件。 EVL在95例出血事件中有92例达到了止血,而静脉曲张破裂出血则有7例立即死亡(7 / 92,7.6%)。除EVL外,其他三种出血事件均导致立即死亡。 EVL是HCC和PVTT患者曲张静脉破裂的一种安全有效的治疗方法。成功止血后,减轻潜在的肝功能损害和控制肿瘤对于良好的预后同样重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号